Compare BioNano Genomics Inc (BNGO) vs First Trust NASDAQ Cybersecurity ETF (CIBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs First Trust NASDAQ Cybersecurity ETF — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while First Trust NASDAQ Cybersecurity ETF trades at $100.16. The key difference: First Trust NASDAQ Cybersecurity ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | CIBR | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | — |
52-Week High | $4.92 | $100.60 |
52-Week Low | $1.06 | $60.74 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
CIBR trades at $99.87, down 0.73% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF has outperformed the S&P 500 year-to-date, driven by strong cybersecurity spending trends exceeding $300 billion in 2026. Recent news highlights institutional activity, including Bank of America reducing its stake while First Trust Advisors increased its position.
The outlook remains positive due to secular growth in cybersecurity demand, though high RSI levels suggest near-term consolidation risk. Key opportunities include AI-driven security expansion, while risks involve sector concentration and market volatility. Analyst sentiment is generally bullish, with upgrades citing reasonable valuations and strong momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About First Trust NASDAQ Cybersecurity ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →
